Coronavirus (COVID-19)
Learn more
April 27, 2017
Sponsor: National Cancer Institute (NCI)
Number: Alchemist A151216
This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer (Click here for lung cancer staging definitions) that has been, or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Who’s eligible:
Pre-surgical patients must have either:
Post-surgical patients must have either:
Available at: The Hospital of Central Connecticut, Hartford Hospital, Backus Hospital- Eastern Connecticut Hematology and Oncology.
Referral Line: 860.972.4700
Get the latest healthcare news directly in your inbox.
Sign up for text alerts / Text MoreLife to 31996.